HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Massimo Cristofanilli Selected Research

Massimo Cristofanilli Research Topics

Disease

69	Breast Neoplasms (Breast Cancer) 11/2015 - 04/2002
67	Neoplasms (Cancer) 11/2015 - 01/2003
25	Neoplasm Metastasis (Metastasis) 10/2015 - 10/2002
24	Inflammatory Breast Neoplasms 11/2015 - 02/2004
12	Carcinoma (Carcinomatosis) 10/2013 - 05/2002
6	Disease Progression 07/2015 - 04/2002
6	Circulating Neoplastic Cells 03/2015 - 07/2009
3	Anemia 09/2015 - 11/2014
2	Neutropenia 07/2015 - 05/2012
2	Prostatic Neoplasms (Prostate Cancer) 12/2014 - 01/2003
2	Pleural Effusion (Pleural Effusions) 01/2013 - 06/2010
2	Lung Neoplasms (Lung Cancer) 09/2009 - 08/2008
2	Lobular Carcinoma 12/2006 - 01/2005
2	Ductal Carcinoma 12/2006 - 01/2005
1	Fatigue 07/2015
1	Thrombocytopenia (Thrombopenia) 07/2015
1	Leukopenia 07/2015
1	Venous Thromboembolism 03/2015
1	Anoxia (Hypoxia) 01/2013
1	Lymphopenia (Lymphocytopenia) 08/2012
1	Infection 05/2012

Drug/Important Bio-Agent (IBA)

20	Estrogens (Estrogen)FDA Link 08/2015 - 07/2003
18	HormonesIBA 10/2015 - 01/2004
13	Epidermal Growth Factor Receptor (EGF Receptor)IBA 08/2015 - 06/2005
11	Paclitaxel (Taxol)FDA LinkGeneric 01/2014 - 02/2004
11	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2013 - 04/2002
8	Progesterone Receptors (Progesterone Receptor)IBA 08/2015 - 12/2006
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2013 - 07/2003
7	docetaxel (Taxotere)FDA Link 05/2012 - 04/2002
6	Biological Markers (Surrogate Marker)IBA 11/2015 - 12/2006
6	trastuzumab (Herceptin)FDA Link 09/2015 - 04/2002
6	Fluorouracil (Carac)FDA LinkGeneric 03/2010 - 05/2002
5	TaxoidsIBA 01/2012 - 05/2002
5	AnthracyclinesIBA 01/2012 - 01/2003
4	lapatinib (GW572016)FDA Link 01/2013 - 06/2010
4	Transcription Factors (Transcription Factor)IBA 11/2012 - 12/2005
4	AntibodiesIBA 06/2009 - 01/2003
3	AntigensIBA 08/2015 - 01/2003
3	Proteins (Proteins, Gene)IBA 01/2013 - 12/2005
3	taxaneIBA 01/2013 - 09/2003
3	Messenger RNA (mRNA)IBA 02/2012 - 09/2005
3	Epidermal Growth Factor (EGF)IBA 12/2011 - 06/2010
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 08/2010 - 02/2009
3	Cadherins (E-Cadherin)IBA 06/2010 - 12/2006
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 06/2010 - 01/2008
3	ParaffinIBA 05/2005 - 11/2003
2	Chemokine ReceptorsIBA 10/2015 - 06/2007
2	HematinicsIBA 09/2015 - 11/2014
2	Biological Tumor Markers (Tumor Markers)IBA 08/2015 - 10/2002
2	fibrin fragment D (D-dimer)IBA 03/2015 - 03/2015
2	tumor-associated antigen GA733IBA 02/2015 - 10/2009
2	Carbon MonoxideIBA 11/2014 - 01/2010
2	erlotinib (CP 358,774)FDA Link 02/2014 - 11/2009
2	erbB-2 Receptor (Receptor, erbB 2)IBA 04/2013 - 02/2007
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2013 - 11/2009
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013 - 09/2009
2	bevacizumab FDA Link 06/2012 - 01/2011
2	CTCE-9908IBA 04/2010 - 08/2009
2	LuciferasesIBA 04/2010 - 08/2009
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 09/2009 - 01/2008
2	kalininIBA 12/2006 - 09/2005
2	CamptothecinIBA 04/2006 - 09/2003
2	Tamoxifen FDA LinkGeneric 05/2005 - 05/2005
1	Carcinoembryonic AntigenIBA 08/2015
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 07/2015
1	fulvestrant (Faslodex)FDA Link 07/2015
1	E-SelectinIBA 06/2015
1	Plasminogen Activators (Plasminogen Activator)IBA 03/2015
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 03/2015
1	Thromboplastin (Tissue Factor)IBA 03/2015
1	hydroquinone (Black and White)FDA Link 01/2015
1	src-Family KinasesIBA 12/2014
1	CCR5 Receptors (CCR5 Receptor)IBA 12/2014
1	AZD 8931IBA 01/2014
1	aldehyde dehydrogenase 1IBA 01/2014
1	Genetic Markers (Genetic Marker)IBA 01/2014
1	Filgrastim (Neupogen)FDA Link 10/2013
1	tipifarnib (R115777)IBA 10/2013
1	TransferasesIBA 10/2013
1	DNA (Deoxyribonucleic Acid)IBA 07/2013
1	pazopanibIBA 01/2013
1	anaplastic lymphoma kinaseIBA 01/2013
1	romidepsin (FK228)FDA Link 01/2013
1	Histone Deacetylase InhibitorsIBA 01/2013
1	2,2- dimethyl- N- (6- oxo- 6,7- dihydro- 5H- dibenzo(b,d)azepin- 7- yl)- N'- (2,2,3,3,3- pentafluoropropyl)malonamideIBA 07/2012
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 07/2012
1	everolimus FDA Link 05/2012

Therapy/Procedure

37	Drug Therapy (Chemotherapy) 09/2015 - 04/2002
8	Heterologous Transplantation (Xenotransplantation) 01/2014 - 12/2008
6	Neoadjuvant Therapy 01/2015 - 07/2003
5	Radiotherapy 05/2011 - 09/2005
3	Segmental Mastectomy (Lumpectomy) 11/2015 - 09/2004
2	Mastectomy (Mammectomy) 11/2015 - 09/2004
2	Palliative Care (Palliative Medicine) 12/2014 - 06/2006
2	Combination Drug Therapy (Combination Chemotherapy) 05/2011 - 01/2011
2	Therapeutics 06/2010 - 06/2010
2	Aftercare (After-Treatment) 04/2008 - 10/2004
1	Intravenous Injections 06/2015
1	Intraperitoneal Injections 07/2013
1	Hematopoietic Stem Cell Transplantation 01/2012